Changing paradigms in Whipple's disease and infection with Tropheryma whipplei

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 10, 2011, Pages 1151-1158

  Moos, V ^a   Schneider, T ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; COTRIMOXAZOLE; DOXYCYCLINE; HYDROXYCHLOROQUINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 16; MEROPENEM; PENICILLIN G; PREDNISOLONE; STREPTOMYCIN; TETRACYCLINE; THALIDOMIDE;

BACTERIAL ENDOCARDITIS; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DRUG EFFICACY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INTERMETHOD COMPARISON; INTESTINE BIOPSY; INTESTINE LIPODYSTROPHY; NONHUMAN; OUTCOME ASSESSMENT; PERIODIC ACID SCHIFF STAIN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEROLOGY; TROPHERYMA WHIPPELII;

ANTI-BACTERIAL AGENTS; HUMANS; TROPHERYMA; WHIPPLE DISEASE;

EID: 80054731653     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1209-y     Document Type: Review

References (64)

1. GH Whipple 1907 A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues Bull Johns Hopkins Hosp 18 382 393 1:CAS:528:DyaD28XotVA%3D
2. T Schneider V Moos C Loddenkemper T Marth F Fenollar D Raoult 2008 Whipple's disease: new aspects of pathogenesis and treatment Lancet Infect Dis 8 3 179 190 18291339 10.1016/S1473-3099(08)70042-2 1:CAS:528:DC%2BD1cXjsl2gsbY%3D
3. JC Lagier H Lepidi D Raoult F Fenollar 2010 Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center Medicine (Baltimore) 89 5 337 345 10.1097/MD. 0b013e3181f204a8
4. D Raoult F Fenollar JM Rolain, et al. 2010 Tropheryma whipplei in children with gastroenteritis Emerg Infect Dis 16 5 776 782 20409366 1:CAS:528:DC%2BC3cXmsFyltLs%3D
5. F Fenollar M Trani B Davoust, et al. 2008 Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates J Infect Dis 197 6 880 887 18419351 10.1086/528693 1:CAS:528:DC%2BD1cXksFKgsro%3D
6. M Schoniger-Hekele D Petermann B Weber C Muller 2007 Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers Appl Environ Microbiol 73 6 2033 2035 17277223 10.1128/AEM.02335-06
7. T Marth N Kleen A Stallmach, et al. 2002 Dysregulated peripheral and mucosal Th1/Th2 response in Whipple's disease Gastroenterology 123 5 1468 1477 12404221 10.1053/gast.2002.36583 1:CAS:528:DC%2BD38XptVGjs7Y%3D
8. V Moos D Kunkel T Marth, et al. 2006 Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple's disease J Immunol 177 3 2015 2022 16849516 1:CAS:528:DC%2BD28XmvFClsLc%3D
9. V Moos C Schmidt A Geelhaar, et al. 2010 Impaired immune functions of monocytes and macrophages in Whipple's disease Gastroenterology 138 1 210 220 19664628 10.1053/j.gastro.2009.07.066 1:CAS:528:DC%2BC3cXht1ajtr4%3D
10. A Geelhaar V Moos K Schinnerling, et al. 2010 Specific and nonspecific B-cell function in the small intestines of patients with Whipple's disease Infect Immun 78 11 4589 4592 20696822 10.1128/IAI.00705-10 1:CAS:528: DC%2BC3cXhsFSntbzF
11. GE Feurle NS Junga T Marth 2010 Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease Gastroenterology 138 2 478 486 19879276 10.1053/j.gastro.2009.10.041 1:CAS:528:DC%2BC3cXivVCnsr4%3D
12. Fenollar F, Rolain JM, Alric L et al. (2009) Resistance to trimethoprim/sulfamethoxazole and Tropheryma whipplei. Int J Antimicrob Agents 34(3):255-259
13. GE Feurle T Marth 1994 An evaluation of antimicrobial treatment for Whipple's disease. Tetracycline versus trimethoprim-sulfamethoxazole Dig Dis Sci 39 8 1642 1648 7519538 10.1007/BF02087770 1:STN:280:DyaK2czis1Gqsw%3D%3D
14. PK Panegyres 2008 Diagnosis and management of Whipple's disease of the brain Pract Neurol 8 5 311 317 18796586 10.1136/jnnp.2008.156836
15. GE Feurle V Moos A Geelhaar, et al. 2010 Immune reconstitution inflammatory syndrome in Whipple disease - an observational cohort study Ann Intern Med 153 710 717 21135294
16. JW Paulley 1952 A case of Whipple's disease (intestinal lipodystrophy) Gastroenterology 22 1 128 133 12980233 1:STN:280:DyaG3s%2FgsVCltw%3D%3D
17. AS Cohen EM Schimmel PR Holt KJ Isselbacher 1960 Ultrastructural abnormalities in Whipple's disease Proc Soc Exp Biol Med 105 411 414 13694342 1:STN:280:DyaF3c%2FhtlKqsg%3D%3D
18. DA Relman TM Schmidt RP MacDermott S Falkow 1992 Identification of the uncultured bacillus of Whipple's disease N Engl J Med 327 5 293 301 1377787 10.1056/NEJM199207303270501 1:CAS:528:DyaK3sXjs1Kl
19. G Schoedon D Goldenberger R Forrer, et al. 1997 Deactivation of macrophages with interleukin-4 is the key to the isolation of Tropheryma whippelii J Infect Dis 176 3 672 677 9291314 10.1086/514089 1:CAS:528: DyaK2sXmtFensbY%3D
20. D Raoult ML Birg B La Scola, et al. 2000 Cultivation of the bacillus of Whipple's disease N Engl J Med 342 9 620 625 10699161 10.1056/ NEJM200003023420903 1:STN:280:DC%2BD3c7ktlSktA%3D%3D
21. B La Scola F Fenollar PE Fournier M Altwegg MN Mallet D Raoult 2001 Description of Tropheryma whipplei gen. nov., sp. nov., the Whipple's disease bacillus Int J Syst Evol Microbiol 51 Pt 4 1471 1479 11491348
22. Dobbins WI (1987) Whipple's disease. Charles C. Thomas, Springfield
23. Martinetti M, Biagi F, Badulli C et al. (2009) The HLA alleles DRB1 13 and DQB1 06 are associated to Whipple's disease. Gastroenterology 136(7):2289-2294
24. A Boulos JM Rolain MN Mallet D Raoult 2005 Molecular evaluation of antibiotic susceptibility of Tropheryma whipplei in axenic medium J Antimicrob Chemother 55 2 178 181 15650004 10.1093/jac/dkh524 1:CAS:528: DC%2BD2MXovVyruw%3D%3D
25. W Li F Fenollar JM Rolain, et al. 2008 Genotyping reveals a wide heterogeneity of Tropheryma whipplei Microbiology 154 Pt 2 521 527 18227256 10.1099/mic.0.2007/011668-0 1:CAS:528:DC%2BD1cXjtFCrsbk%3D
26. SD Bentley M Maiwald LD Murphy, et al. 2003 Sequencing and analysis of the genome of the Whipple's disease bacterium Tropheryma whipplei Lancet 361 9358 637 644 12606174 10.1016/S0140-6736(03)12597-4 1:CAS:528: DC%2BD3sXhsVajt7s%3D
27. D Raoult H Ogata S Audic, et al. 2003 Tropheryma whipplei Twist: a human pathogenic Actinobacteria with a reduced genome Genome Res 13 8 1800 1809 12902375 1:CAS:528:DC%2BD3sXmsVWqt7k%3D
28. M Kowalczewska C Villard D Lafitte F Fenollar D Raoult 2009 Global proteomic pattern of Tropheryma whipplei: a Whipple's disease bacterium Proteomics 9 6 1593 1616 19253299 10.1002/pmic.200700889 1:CAS:528: DC%2BD1MXksVKqsr0%3D
29. N Crapoulet P Barbry D Raoult P Renesto 2006 Global transcriptome analysis of Tropheryma whipplei in response to temperature stresses J Bacteriol 188 14 5228 5239 16816195 10.1128/JB.00507-06 1:CAS:528:DC%2BD28XntFWmtbo%3D
30. CJ Bonhomme P Renesto B Desnues, et al. 2009 Tropheryma whipplei glycosylation in the pathophysiologic profile of Whipple's disease J Infect Dis 199 7 1043 1052 19222368 10.1086/597277 1:CAS:528:DC%2BD1MXksVWgu7s%3D
31. D Raoult F Fenollar ML Birg 2006 Culture of T. whipplei from the stool of a patient with Whipple's disease N Engl J Med 355 14 1503 1505 17021332 10.1056/NEJMc061049 1:CAS:528:DC%2BD28XhtVGgt77F
32. JM Rolain F Fenollar D Raoult 2007 False positive PCR detection of Tropheryma whipplei in the saliva of healthy people BMC Microbiol 7 48 17535423 10.1186/1471-2180-7-48
33. S Bousbia L Papazian JP Auffray, et al. 2010 Tropheryma whipplei in patients with pneumonia Emerg Infect Dis 16 2 258 263 20113556
34. F Fenollar O Mediannikov C Socolovschi, et al. 2010 Tropheryma whipplei bacteremia during fever in rural West Africa Clin Infect Dis 51 5 515 521 20658941 10.1086/655677
35. F Fenollar JF Trape H Bassene C Sokhna D Raoult 2009 Tropheryma whipplei in fecal samples from children, Senegal Emerg Infect Dis 15 6 922 924 19523292 10.3201/eid1506.090182
36. R Escher S Roth S Droz K Egli M Altwegg MG Tauber 2010 Endocarditis due to Tropheryma whipplei: rapid detection, limited genetic diversity, and long-term clinical outcome in a local experience Clin Microbiol Infect 16 8 1213 1222 19732090 10.1111/j.1469-0691.2009.03038.x 1:CAS:528:DC%2BC3cXhtFCgtbzN
37. F Fenollar H Lepidi D Raoult 2001 Whipple's endocarditis: review of the literature and comparisons with Q fever, Bartonella infection, and blood culture-positive endocarditis Clin Infect Dis 33 8 1309 1316 11565070 10.1086/322666 1:STN:280:DC%2BD3Mrhslaltg%3D%3D
38. C Mallmann S Siemoneit D Schmiedel, et al. 2010 Fluorescence in situ hybridization to improve the diagnosis of endocarditis: a pilot study Clin Microbiol Infect 16 6 767 773 19694763 10.1111/j.1469-0691.2009.02936.x 1:CAS:528:DC%2BC3cXot1Gmsb4%3D
39. W Geissdorfer I Wittmann M Rollinghoff C Schoerner C Bogdan 2001 Detection of a new 16 S-23 S rRNA spacer sequence variant (type 7) of Tropheryma whippelii in a patient with prosthetic aortic valve endocarditis Eur J Clin Microbiol Infect Dis 20 10 762 763 11757986 10.1007/s100960100588 1:STN:280:DC%2BD38%2FivF2qtQ%3D%3D
40. R Mahnel A Kalt S Ring A Stallmach W Strober T Marth 2005 Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations Am J Gastroenterol 100 5 1167 1173 15842595 10.1111/j.1572-0241.2005.40128.x 1:CAS:528:DC%2BD2MXkvVSmsLg%3D
41. DV Durand C Lecomte P Cathebras H Rousset P Godeau 1997 Whipple disease. Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Societe Nationale Francaise de Medecine Interne Med Baltim 76 3 170 184 10.1097/00005792-199705000-00003 1:STN:280:DyaK2szjs1Ojtw%3D%3D
42. A Gerard F Sarrot-Reynauld E Liozon, et al. 2002 Neurologic presentation of Whipple disease: report of 12 cases and review of the literature Med Baltim 81 6 443 457 10.1097/00005792-200211000-00005
43. H Pruss J Katchanov R Zschenderlein C Loddenkemper T Schneider V Moos 2007 A patient with cerebral Whipple disease with gastric involvement but no gastrointestinal symptoms: a consequence of local protective immunity? J Neurol Neurosurg Psychiatry 78 8 896 898 17371903 10.1136/jnnp.2006.110908
44. A von Herbay M Maiwald HJ Ditton HF Otto 1996 Histology of intestinal Whipple's disease revisited. A study of 48 patients Virchows Arch 429 6 335 343 10.1007/BF00198437
45. A von Herbay HJ Ditton M Maiwald 1996 Diagnostic application of a polymerase chain reaction assay for the Whipple's disease bacterium to intestinal biopsies Gastroenterology 110 6 1735 1743 10.1053/gast.1996.v110. pm8964398
46. F Fenollar S Laouira H Lepidi JM Rolain D Raoult 2008 Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of Whipple disease: usefulness of saliva and stool specimens for first-line screening Clin Infect Dis 47 5 659 667 18662136 10.1086/590559
47. N Bakkali F Fenollar S Biswas JM Rolain D Raoult 2008 Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene J Infect Dis 198 1 101 108 18500934 10.1086/588706 1:CAS:528:DC%2BD1cXos1Wrtrs%3D
48. BL Baisden H Lepidi D Raoult P Argani JH Yardley JS Dumler 2002 Diagnosis of Whipple disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whipplei (the Whipple bacillus) in paraffin-embedded tissue Am J Clin Pathol 118 5 742 748 12428795 10.1309/8YGR-FE7L-39LL-L37C 1:CAS:528:DC%2BD38XovFWqsbY%3D
49. M Kowalczewska F Fenollar D Lafitte D Raoult 2006 Identification of candidate antigen in Whipple's disease using a serological proteomic approach Proteomics 6 11 3294 3305 16637011 10.1002/pmic.200500171 1:CAS:528: DC%2BD28Xmt1art7Y%3D
50. CJ Bonhomme P Renesto S Nandi AM Lynn D Raoult 2008 Serological microarray for a paradoxical diagnostic of Whipple's disease Eur J Clin Microbiol Infect Dis 27 10 959 968 18594884 10.1007/s10096-008-0528-0 1:CAS:528:DC%2BD1cXht1amsrzL
51. F Fenollar B Amphoux D Raoult 2009 A paradoxical Tropheryma whipplei western blot differentiates patients with Whipple disease from asymptomatic carriers Clin Infect Dis 49 5 717 723 19635029 10.1086/604717 1:CAS:528:DC%2BD1MXhtFOju7bI
52. RD Keinath DE Merrell R Vlietstra WO Dobbins 3rd 1985 Antibiotic treatment and relapse in Whipple's disease. Long-term follow-up of 88 patients Gastroenterology 88 6 1867 1873 2581843 1:STN:280:DyaL2M3gsFWlsA%3D%3D
53. JC Lagier F Fenollar H Lepidi D Raoult 2010 Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease J Antimicrob Chemother 65 9 2005 2012 20639526 10.1093/jac/dkq263 1:CAS:528:DC%2BC3cXhtVansbjJ
54. WR Cannon 2003 Whipple's disease, genomics, and drug therapy Lancet 361 9372 1916 12788617 10.1016/S0140-6736(03)13533-7
55. T Schneider A Stallmach A von Herbay T Marth W Strober M Zeitz 1998 Treatment of refractory Whipple disease with interferon-gamma Ann Intern Med 129 11 875 877 9867729 1:STN:280:DyaK1M%2Fktlaisw%3D%3D
56. JC Lagier F Fenollar H Lepidi E Liozon D Raoult 2010 Successful treatment of immune reconstitution inflammatory syndrome in Whipple's disease using thalidomide J Infect 60 1 79 82 19852981 10.1016/j.jinf.2009.09.017
57. C Pauletti F Pujia M Accorinti, et al. 2010 An atypical case of neuro-Whipple: Clinical presentation, magnetic resonance spectroscopy and follow-up J Neurol Sci 297 1-2 97 100 20674936 10.1016/j.jns.2010.07.001
58. PK Panegyres R Edis M Beaman M Fallon 2006 Primary Whipple's disease of the brain: characterization of the clinical syndrome and molecular diagnosis QJM 99 9 609 623 16905752 10.1093/qjmed/hcl081 1:STN:280:DC%2BD28rgvVChsw%3D%3D
59. GE Thwaites DB Nguyen HD Nguyen, et al. 2004 Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults N Engl J Med 351 17 1741 1751 15496623 10.1056/NEJMoa040573 1:CAS:528:DC%2BD2cXovFSktrY%3D
60. D Raoult H Lepidi JR Harle 2001 Tropheryma whipplei circulating in blood monocytes N Engl J Med 345 7 548 11519522 10.1056/NEJM200108163450716 1:STN:280:DC%2BD3Mvns1Wjuw%3D%3D
61. A Kalt T Schneider S Ring, et al. 2006 Decreased levels of interleukin-12p40 in the serum of patients with Whipple's disease Int J Colorectal Dis 21 2 114 120 15875203 10.1007/s00384-005-0778-6 1:STN:280:DC%2BD28%2FltVOlsA%3D%3D
62. K Al Moussawi E Ghigo U Kalinke L Alexopoulou JL Mege B Desnues 2010 Type I interferon induction is detrimental during infection with the Whipple's disease bacterium, Tropheryma whipplei PLoS Pathog 6 1 e1000722 20090833 10.1371/journal.ppat.1000722
63. B Desnues D Raoult JL Mege 2005 IL-16 is critical for Tropheryma whipplei replication in Whipple's disease J Immunol 175 7 4575 4582 16177102 1:CAS:528:DC%2BD2MXhtVWltbvF
64. E Ghigo AO Barry L Pretat, et al. 2010 IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation PLoS ONE 5 10 e13561 21042409 10.1371/journal.pone.0013561